Global Parenteral Nutrition Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Parenteral Nutrition Market is presumed to reach the market size of nearly USD 13.41 Billion by 2032 from USD 7.61 Billion in 2023 with a CAGR of 6.49% under the study period 2024-2032.

Parenteral nutrition delivers essential nutrients directly into the bloodstream when a patient's digestive system cannot absorb nutrients from food. Administered intravenously, these nutrition solutions contain a balanced mix of carbohydrates, proteins, fats, vitamins, and minerals tailored to meet the patient's nutritional needs. This specialized form of nutrition support is commonly utilized in critical care settings for patients experiencing severe malnutrition, gastrointestinal disorders, or those undergoing major surgeries.

MARKET DYNAMICS

The factors driving the parenteral nutrition market include the growing incidence of chronic diseases, spurring several surgical procedures, and the expanding geriatric population worldwide. Parenteral nutrition is crucial in managing malnutrition, supporting recovery from surgery, and maintaining health in critically ill patients. Moreover, advancements in medical technology and formulations have spurred the creation of specialized solutions designed to address the nutritional requirements of particular patient groups, such as premature infants, cancer patients, and individuals with gastrointestinal disorders. Additionally, the expanding applications of this nutrition in home healthcare settings and ambulatory care further drive market growth. Furthermore, the growing adoption of total parenteral nutrition (TPN) and peripheral parenteral nutrition (PPN) in hospitals and healthcare facilities and increasing healthcare expenditure and reimbursement policies contribute to the market's expansion. However, regulatory constraints and limited reimbursement options may hinder the market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Parenteral Nutrition. The growth and trends of Parenteral Nutrition industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Parenteral Nutrition market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Nutrient

Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

By Stage

Adult
Pediatrics

By Indication

Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Online Sales
Retail Sales
Institutional Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Parenteral Nutrition market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Nutrition market include Baxter, Grifols, S.A., Allergan, Otsuka Pharmaceutical Factory Inc., Actavis Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co. Ltd., Pfizer Inc. (Hospira Inc.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11213929

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PARENTERAL NUTRITION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Nutrient
- 3.7.2 Market Attractiveness Analysis By Stage
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Sales Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY NUTRIENT

5.1. Overview By Nutrient
5.2. Historical and Forecast Data
5.3. Analysis By Nutrient
5.4. Carbohydrates Historic and Forecast Sales By Regions
5.5. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
5.6. Single Dose Amino Acid Solution Historic and Forecast Sales By Regions
5.7. Trace Elements Historic and Forecast Sales By Regions
5.8. Vitamins & Minerals Historic and Forecast Sales By Regions

6. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY STAGE

6.1. Overview By Stage
6.2. Historical and Forecast Data
6.3. Analysis By Stage
6.4. Adult Historic and Forecast Sales By Regions
6.5. Pediatrics Historic and Forecast Sales By Regions

7. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Alzheimer's Historic and Forecast Sales By Regions
7.5. Nutrition Deficiency Historic and Forecast Sales By Regions
7.6. Cancer Care Historic and Forecast Sales By Regions
7.7. Diabetes Historic and Forecast Sales By Regions
7.8. Chronic Kidney Diseases Historic and Forecast Sales By Regions
7.9. Orphan Diseases Historic and Forecast Sales By Regions
7.10. Dysphagia Historic and Forecast Sales By Regions
7.11. Pain Management Historic and Forecast Sales By Regions
7.12. Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales By Regions
7.13. Others Historic and Forecast Sales By Regions

8. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY SALES CHANNEL

8.1. Overview By Sales Channel
8.2. Historical and Forecast Data
8.3. Analysis By Sales Channel
8.4. Online Sales Historic and Forecast Sales By Regions
8.5. Retail Sales Historic and Forecast Sales By Regions
8.6. Institutional Sales Historic and Forecast Sales By Regions

9. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PARENTERAL NUTRITION COMPANIES

10.1. Parenteral Nutrition Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PARENTERAL NUTRITION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Baxter
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Grifols
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. S.A.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Allergan
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Otsuka Pharmaceutical Factory Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Actavis Inc.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. B. Braun Melsungen AG
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Fresenius Kabi AG
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Vifor Pharma
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sichuan Kelun Pharmaceutical Co. Ltd.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Pfizer Inc. (Hospira Inc.)
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies